OPTIMIZATION OF SODIUM DEOXYCHOLATE-BASED TRANSFERSOMES FOR PERCUTANEOUS DELIVERY OF PEPTIDES AND PROTEINS
Objective: This study aims to formulate and characterize the transfersomes for percutaneous delivery of peptides and proteins. In particular, this study was a preliminary study for the transfersomes formulation of recombinant human epidermal growth factor (rhEGF) for topical delivery.
Methods: The transfersomes was prepared by thin film hydration method using phosphatidylcholine and sodium deoxycholate as vesicle former. In this study, transfersomes formulas were optimized, namely TF1, TF2, TF3, and TF4 with several ratios of phospholipid and surfactant which were 90:10, 85:15, 80:20, and 75:25, respectively. Afterward, the transfersomes were characterized in terms of particle size distribution, polydispersity index, zeta potential, morphology of vesicles, and deformability index.
Results: The results showed that the best formulation was TF3 with the ratio of 80:20 with a particle size of 118.6±1.33 nm, polydispersity index of 0.102±0.011, zeta potential of-30.9±0,46 mV, and deformability index of 1.182±0.08. TEM analysis also showed spherical and unilamellar vesicles of transfersomes.
Conclusion: This work demonstrated that the sodium deoxycholate-based transfersomes could be potential to be further formulated with peptide and protein for percutaneous delivery.
2. Namjoshi S, Caccetta R, Benson HAE. Skin peptides: biological activity and therapeutic opportunities. J Pharm Sci 2008;97:2524–42.
3. Caussa JE, Vila EH. Epidermal growth factor, innovation and safety. Med Clin 2015;145:305–12.
4. Bouwstra JA, Honeywell Nguyen PL, Gooris GS, Ponec M. Structure of the skin barrier and its modulation by vesicular formulations. Prog Lipid Res 2003;42:1–36.
5. Badenhorst T, Svirckis D, Wu Z. Pharmaceutical strategies for the topical dermal delivery of peptides/proteins for cosmetic and therapeutic applications. Austin J Pharmacol Ther 2014;2:1–10.
6. Chaulagain B, Jain A, Tiwari A, Verma A, Jain SK. Passive delivery of protein drugs through transdermal route. Artif Cells Nanomed Biotechnol 2018;46 Suppl1:472–87.
7. Ascenso A, Raposo S, Catia B, Cardoso P, Mendes T, Praca FG, et al. Development, characterization, and skin delivery studies of related ultradeformable vesicles: transfersomes, ethosomes, and transethosomes. Int J Nanomed 2015;10:5837–51.
8. Prajapati ST, Patel CG, Patel CN. Transfersomes: a vesicular carrier system for transdermal drug delivery. Asian J Biochem Pharm Res 2011;1:507–24.
9. Holm R, Müllertz A, Mu H. Bile salts and their importance for drug absorption. Int J Pharm 2013;453:44–5.
10. Aburahma MH. Bile salts-containing vesicles: promising pharmaceutical carriers for oral delivery of poorly water-soluble drugs and peptide/protein-based therapeutics or vaccines. Drug Delivery 2016;23:1847–67.
11. Malakar J, Oomen S, Nayak AK. Formulation, optimization and evaluation of transferosomal gel for transdermal insulin delivery. Saudi Pharm J 2012;20:355–63.
12. Pawar A, Jadhav KR, Chaudhari LH. Transfersome: a novel technique which improves transdermal permeability. Asian J Pharm 2016;10:425–36.
13. Bnyan R, Khan I, Ehtezazi T, Saleem I, Gordon S, Francis ON, et al. Surfactant effects on lipid-based vesicles properties. J Pharm Sci 2018;107:1237–46.
14. Maggio ET. Polysorbates, peroxides, protein aggregation, and immunogenicity–a growing concern. J Excipients Food Chem 2012;3:45–53.
15. Abdallah MA. Transfersomes as a transdermal drug delivery system for enhancement the antifungal activity of nystatin. Int J Pharm Pharm Sci 2013;5:560-7.
16. Shaji J, Lal M. Praparation, optimization, and evaluation of transfersomal formulation for enhanced transdermal delivery of a COX-2 inhibitor. Int J Pharm Pharm Sci 2014;6:467–77.
17. Grimaldi N, Andrade F, Segovia N, Ferrer Tasies L, Sala S, Veciana J, et al. Lipid-based nanovesicles for nanomedicines. Chem Soc Rev 2016;45:6520–45.
18. Patil YP, Jadhav S. Novel methods for liposome preparation. Chem Phys Lipids 2014;177:8–18.
19. Lapinski MM, Castro-forero A, Greiner AJ, Ofoli RY, Blanchard GJ. Comparison of liposomes formed by sonication and extrusion: Rotational and translational diffusion of an embedded chromophore. Langmuir 2007;23:11677–83.
20. Awad RS, Abdelwahed W, Bitar Y. Evaluating the impact of preparation conditions and formulation on the accelerated stability of tretinoin loaded liposomes prepared by heating method. Int J Pharm Pharm Sci 2015;7:171-8.
21. Singh S, Vardhan H, Kotla NG, Maddiboyina B, Sharma D, Webster TJ. The role of surfactants in the formulation of elastic liposomal gels containing a synthetic opioid analgesic. Int J Nanomed 2016;11:1475–82.
22. Malvern. Zetasizer nano series user manual. Worcestershire: Malvern Instruments Ltd; 2013.
23. Duangjit S, Opanasopit P, Rojanarata T, Ngawhirunpat T. Characterization and in vitro skin permeation of meloxicam-loaded liposomes versus transfersomes. J Drug Delivery 2011;2011:418316.
24. Surini S, Sarah, Djajadisastra J. Formulation and in vitro penetration study of transfersomes gel containing gotu kola leaves extract (Centella asiatica L. Urban). J Young Pharm 2018;10:27–31.
25. Yusuf M, Sharma V, Pathak K. Nanovesicles for transdermal delivery of felodipine: development, characterization, and pharmacokinetics. Int J Pharm Invest 2014;4:119–30.
26. Gonzalez Rodriguez ML, Arroyo CM, Cozar Bernal MJ, Gonzalez R PL, Leon JM, Calle M, et al. Deformability properties of timolol-loaded transfersomes based on the extrusion mechanism. Statistical optimization of the process. Drug Dev Ind Pharm 2016;42:1683–94.
27. Anwar E, Utami TD, Ramadon D. Transfersomal gel containing green tea (Camelia sinensis L. Kuntze) leaves extract: increasing in vitro penetration. Asian J Pharm Clin Res 2017;10:294-8.
This work is licensed under a Creative Commons Attribution 4.0 International License.